BACKGROUND: Tuberous sclerosis complex (TSC) is associated with tumor development in the brain, retina, kidney, skin, heart, and lung. Seizures, intellectual disability, and characteristic skin lesions commonly manifest in early childhood, but some findings, notably renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM), emerge later, placing adults with undiagnosed TSC at increased risk for morbidity and mortality. OBJECTIVE: To describe the clinical presentation and severity of TSC in adult women. DESIGN: Retrospective cohort study. SETTING: National Institutes of Health Clinical Center, Bethesda, Maryland, 1995 to 2010. PATIENTS: 79 women aged 18 years or older who were enrolled in an observational cohort study of TSC to evaluate disease manifestations. MEASUREMENTS: History, physical examination, pulmonary function testing, chest radiography, abdominal computed tomography, high-resolution chest computed tomography, and brain magnetic resonance imaging were used to evaluate patients. RESULTS: Among the 45 patients who received a diagnosis of TSC in adulthood, 21 presented with symptoms due to LAM, 19 with renal angiomyolipomas, and 10 with seizures. Of the 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years and 15 were older than 18 years before meeting the clinical criteria for TSC. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death. LIMITATION: No men were included in the study, and selection was biased toward patients having pulmonary LAM. CONCLUSION: Women who received a TSC diagnosis in adulthood had minimal morbidity during childhood but were still at risk for life-threatening pulmonary and renal manifestations. PRIMARY FUNDING SOURCE: Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.
BACKGROUND:Tuberous sclerosis complex (TSC) is associated with tumor development in the brain, retina, kidney, skin, heart, and lung. Seizures, intellectual disability, and characteristic skin lesions commonly manifest in early childhood, but some findings, notably renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM), emerge later, placing adults with undiagnosed TSC at increased risk for morbidity and mortality. OBJECTIVE: To describe the clinical presentation and severity of TSC in adult women. DESIGN: Retrospective cohort study. SETTING: National Institutes of Health Clinical Center, Bethesda, Maryland, 1995 to 2010. PATIENTS: 79 women aged 18 years or older who were enrolled in an observational cohort study of TSC to evaluate disease manifestations. MEASUREMENTS: History, physical examination, pulmonary function testing, chest radiography, abdominal computed tomography, high-resolution chest computed tomography, and brain magnetic resonance imaging were used to evaluate patients. RESULTS: Among the 45 patients who received a diagnosis of TSC in adulthood, 21 presented with symptoms due to LAM, 19 with renal angiomyolipomas, and 10 with seizures. Of the 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years and 15 were older than 18 years before meeting the clinical criteria for TSC. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death. LIMITATION: No men were included in the study, and selection was biased toward patients having pulmonary LAM. CONCLUSION:Women who received a TSC diagnosis in adulthood had minimal morbidity during childhood but were still at risk for life-threatening pulmonary and renal manifestations. PRIMARY FUNDING SOURCE: Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.
Authors: Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash Journal: Urology Date: 2008-09-21 Impact factor: 2.649
Authors: David H Ewalt; Norman Diamond; Chet Rees; Steven P Sparagana; Mauricio Delgado; Lori Batchelor; E Steve Roach Journal: J Urol Date: 2005-11 Impact factor: 7.450
Authors: An C Jansen; Ozgur Sancak; Maria Daniela D'Agostino; AmanPreet Badhwar; Penelope Roberts; Gabriella Gobbi; Ralph Wilkinson; Denis Melanson; Donatella Tampieri; Robert Koenekoop; Mark Gans; Anneke Maat-Kievit; Miriam Goedbloed; Ans M W van den Ouweland; Mark Nellist; Massimo Pandolfo; Mary McQueen; Katherine Sims; Elisabeth A Thiele; François Dubeau; Frederick Andermann; David J Kwiatkowski; Dicky J J Halley; Eva Andermann Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Joshua D Sparling; Chien-Hui Hong; Jaime S Brahim; Joel Moss; Thomas N Darling Journal: J Am Acad Dermatol Date: 2007-01-19 Impact factor: 11.527
Authors: John J Bissler; Francis X McCormack; Lisa R Young; Jean M Elwing; Gail Chuck; Jennifer M Leonard; Vincent J Schmithorst; Tal Laor; Alan S Brody; Judy Bean; Shelia Salisbury; David N Franz Journal: N Engl J Med Date: 2008-01-10 Impact factor: 91.245
Authors: Neera Nathan; Kim M Keppler-Noreuil; Leslie G Biesecker; Joel Moss; Thomas N Darling Journal: Dermatol Clin Date: 2017-01 Impact factor: 3.478
Authors: Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto Journal: Am J Med Genet C Semin Med Genet Date: 2016-11-18 Impact factor: 3.908
Authors: Brianna P Matthew; Amir M Hasani; Yun-Ching Chen; Mehdi Pirooznia; Mario Stylianou; Shirley F Rollison; Tania R Machado; Nora M Quade; Amanda M Jones; Patricia Julien-Williams; Angelo Taveira-DaSilva; Marcus Y Chen; Joel Moss; Han Wen Journal: Chest Date: 2021-02-05 Impact factor: 9.410